NYSE:ARR charts & data provided by TradingView

Latest Insights on ARR

Netflix’s massively disappointing report last week presents a low-risk buying opportunity for a few old-media “dinosaurs” as CEO Reed Hastings contemplates his next move. Netflix’s Kryptonite: A Low-Risk Buyout Opportunity July 23, 2019 by Jeff Yastine Investment Opportunities, Stocks, Winning Investor Daily Netflix’s massively disappointing report last week presents a low-risk buying opportunity for a few old-media “dinosaurs” as CEO Reed Hastings contemplates his next move.
Great Stuff 7-23-2019 The $1 Billion 5G Deal With Intel Won’t Save Apple July 23, 2019 by Joseph Hargett Great Stuff We get some interesting mail here at Great Stuff. You never know what’s going to show up in the GreatStuffToday@banyanhill.com inbox. I’ve seen everything from stock advice to insults to poetry. After last week’s Reader Feedback issue, I received a rather interesting question from Edward M.: In 30 years of financial writing, an economics writer […]
Great Stuff 7-22-2019 Earnings Food for Thought: McDonald’s, Chipotle and Starbucks July 22, 2019 by Joseph Hargett Great Stuff I have a weakness for ramen. Not the cheap Maruchan stuff that we lived on in college, but the “boutique” stuff you find at your local ramen-bowl restaurants. This weakness proved to be my undoing this morning. I had a bowl of some spicy, chicken-fire ramen last night … and I’m still on fire today. […]
Every analyst agrees a bear market is defined as a 20% decline from a high. But in old books, the definition of a bear market is more detailed. Ignore the “Experts”: We’re in a Bear Market July 22, 2019 by Michael Carr Stocks, U.S. Economy, Winning Investor Daily Every analyst agrees a bear market is defined as a 20% decline from a high. But in old books, the definition of a bear market is more detailed.
Jeff Yastine and Ted Bauman share their thoughts on one of the hottest sectors right now: biotech. Biotech Boom: Grab Big Winners, Avoid the Flops July 20, 2019 by Jay Goldberg Investment Opportunities, Technology, Winning Investor Daily Jeff Yastine and Ted Bauman share their thoughts on one of the hottest sectors right now: biotech.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This